Retour
Fourchette du Jour
70,67 €
73,93 €
Fourchette 52 Semaines
6,45 €
77,00 €
Volume
659 166
Moyenne 50J / 200J
56,05 €
/
44,68 €
Clôture Précédente
74,34 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,0 | 0,3 |
| P/B | 16,5 | 2,9 |
| ROE % | -217,9 | 3,7 |
| Net Margin % | -297,1 | 3,8 |
| Rev Growth 5Y % | -14,2 | 10,0 |
| D/E | 1,7 | 0,2 |
Objectif de Cours des Analystes
Hold
136,40 €
+87.0%
Low: 105,00 €
High: 165,00 €
BPA Prévisionnel
-10,10 €
CA Est.
41 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-10,44 €
-12,84 € – -3,55 €
|
210 M | 6 |
| FY2029 |
-12,81 €
-15,75 € – -4,35 €
|
110 M | 6 |
| FY2028 |
-12,96 €
-19,89 € – -9,78 €
|
54 M | 8 |
Points Clés
Revenue declined -14,20% annually over 5 years
Negative free cash flow of -208,68M
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,69%
Capital efficient — spends only 0,31% of revenue on capex
Croissance
Revenue Growth (5Y)
-14,20%
Revenue (1Y)-43,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-217,94%
ROIC-41,08%
Net Margin-297,07%
Op. Margin-236,77%
Sécurité
Debt / Equity
1,66
Current Ratio4,97
Interest Coverage-4,99
Valorisation
P/E Ratio
-9,03
P/B Ratio16,48
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -43,89% | Revenue Growth (3Y) | -21,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14,20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 55,23M | Net Income (TTM) | -164,08M |
| ROE | -217,94% | ROA | -58,51% |
| Gross Margin | 100,00% | Operating Margin | -236,77% |
| Net Margin | -297,07% | Free Cash Flow (TTM) | -208,68M |
| ROIC | -41,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,66 | Current Ratio | 4,97 |
| Interest Coverage | -4,99 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,03 | P/B Ratio | 16,48 |
| P/S Ratio | 26,81 | PEG Ratio | -0,36 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,48B | Enterprise Value | 1,61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 55,23M | 98,43M | 90,12M | 92,06M | 101,91M |
| Net Income | -164,08M | -118,96M | -276,06M | -368,20M | -523,84M |
| EPS (Diluted) | -9,73 | -8,68 | -21,79 | -29,51 | -42,90 |
| Gross Profit | 55,23M | 67,74M | 53,48M | 70,42M | 77,01M |
| Operating Income | -130,77M | -105,20M | -137,43M | -240,24M | -446,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 280,41M | 303,85M | 398,03M | 710,60M | 1,12B |
| Total Liabilities | 190,57M | 243,11M | 267,05M | 343,96M | 437,68M |
| Shareholders' Equity | 89,83M | 60,74M | 130,99M | 366,64M | 679,51M |
| Total Debt | 148,91M | 102,56M | 117,78M | 131,50M | 143,18M |
| Cash & Equivalents | 15,12M | 44,25M | 35,28M | 88,23M | 25,22M |
| Current Assets | 266,27M | 261,29M | 330,70M | 545,97M | 795,58M |
| Current Liabilities | 53,54M | 61,40M | 51,27M | 68,20M | 85,20M |